Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients

Immunotherapy has been a new standard for recurrent/metastatic head and neck cancers (R/M HNC). One of the prominent characteristics of cancer immunotherapy is the induction of immune memory followed by endured treatment response. However, whether and how a treatment delay would impact on the effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gaili, Wu, Qiuji, Jiang, Huangang, Li, Zheng, Hua, Xinying, Hu, Xiaoyan, Yu, Haijun, Xie, Conghua, Zhong, Yahua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729699/
https://www.ncbi.nlm.nih.gov/pubmed/33308264
http://dx.doi.org/10.1186/s13045-020-01019-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729699/
https://www.ncbi.nlm.nih.gov/pubmed/33308264
http://dx.doi.org/10.1186/s13045-020-01019-5

Ejemplares similares